Biotech Says Solomon Wasn't Involved In AstraZeneca Deal
A British biotech company, formerly known as Spirogen Ltd., told a New York federal judge Wednesday that investment banking advisory firm Peter J. Solomon Co. had never worked on its $200...To view the full article, register now.
Already a subscriber? Click here to view full article